Back to Federated Hermes, Inc. Federated Hermes, Inc.

NVAXNVAX

Showing 8 of 27 quarters

Position history for Federated Hermes, Inc.Federated Hermes, Inc.'s holdings in Novavax, Inc.

Yes. Federated Hermes holds 703,006 shares of NVAX (Novavax), worth $6.6M, as of its Q2 2026 13F filing. It increased the position from 4,753 shares in Q1 2026. Federated Hermes has held NVAX since Q3 2025, across 4 quarterly 13F filings.

Current Value

$6.6M

Current Shares

703,006

Total Value Change

+$6M

Total Shares Change

+654,624

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
703,006
+147x
$6.6M0.0%$9.42
44
2026-Q1
Increased
4,753
+53.7%
$38,6890.0%$8.14
28
2025-Q4
Increased
3,093
+347.0%
$20,7850.0%$6.72
21
2025-Q3
New
692
—
$6,0000.0%$8.67
24
2025-Q2
Exited
0
-100.0%
$00.0%$6.30
0
2025-Q1
Increased
56,124
+11.1%
$359,7550.0%$6.41
26
2024-Q4
Increased
50,506
+4.4%
$406,0680.0%$8.04
25
2024-Q3
Decreased
48,382
-2.1%
$611,0650.0%$12.63
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used